CNS Pharmaceuticals announces 1-for-50 reverse stock split effective June 4, 2024 to meet Nasdaq minimum bid price

CNS Pharmaceuticals, Inc.

1-for-50 reverse stock split effective 4:01 PM ET June 4, 2024; trading on split-adjusted basis from June 5, 2024 under symbol CNSP.
Outstanding shares reduced from ~16.25M to ~325K; authorized shares remain 300M; par value unchanged at $0.001.
No fractional shares issued; fractional shares rounded up to nearest whole share.
Split intended to increase per share trading price to comply with Nasdaq minimum bid price listing requirement.
Warrants and equity awards proportionally adjusted: shares underlying divided by 50, exercise price multiplied by 50.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.